Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 38Carcinoma, Transitional Cell 3Urologic Diseases 2Urinary Bladder Diseases 2Muscle Invasive Bladder Cancer 2Infiltrating Bladder Urothelial Carcinoma 2Carcinoma, Renal Cell 2Wound Infection 1Urologic Neoplasms 1Urinary Tract Infections 1Ureteral Neoplasms 1Transitional Cell Carcinoma of the Bladder 1Transitional Cell Bladder Cancer 1Stage 0is Bladder Urothelial Carcinoma 1Recurrence 1Prostatic Neoplasms 1Patient Satisfaction 1Non-metastatic Muscle Invasive Bladder Cancer 1Neoplasms 1Invasive Bladder Cancer 1Infections 1Ileus 1Disease Progression 1Cross Infection 1Cone Dystrophy 3 1Bladder Adenocarcinoma 1Bacterial Infections 1Adrenal Gland Neoplasms 1

Interventions

pembrolizumab 2fludarabine 2Radiosurgery 2Paclitaxel 2Gemcitabine 2Cyclophosphamide 2Cisplatin 2Carboplatin 2Anthropogenic Effects 2venetoclax 1umbralisib 1ublituximab 1regorafenib 1pazopanib 1niraparib 1neratinib 1lutetium Lu 177 dotatate 1ibrutinib 1grapiprant 1fludarabine phosphate 1famitinib 1encorafenib 1copanlisib 1cemiplimab 1capivasertib 1camrelizumab 1brigatinib 1binimetinib 1axicabtagene ciloleucel 1avelumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Disease Progression × Cystectomy × Clear all
NCT06170177 2023-12-14

Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy

IRCCS San Raffaele

Recruiting
4,000 enrolled
Genitourinary

Urinary Bladder Neoplasms, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡